ProfileGDS4132 / 219211_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 53% 61% 35% 39% 46% 50% 49% 40% 33% 39% 48% 47% 43% 44% 36% 41% 52% 55% 42% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101143.69853
GSM201543Muscle PCOS pioglitazone 121165.0361
GSM201544Muscle PCOS pioglitazone 16189.953935
GSM201545Muscle PCOS pioglitazone 201109.73839
GSM201829Muscle PCOS pioglitazone 231128.7146
GSM201830Muscle PCOS pioglitazon 251137.90650
GSM201831Muscle PCOS pioglitazone 271133.87349
GSM201832Muscle PCOS pioglitazone 31101.51640
GSM201833Muscle PCOS pioglitazone 4178.944333
GSM201834Muscle PCOS pioglitazone 8197.422639
GSM201835Muscle PCOS after pioglitazone 102113.94948
GSM201836Muscle PCOS after pioglitazone 122114.73447
GSM201837Muscle PCOS after pioglitazone 16295.071443
GSM201838Muscle PCOS after pioglitazone 202104.33844
GSM201839Muscle PCOS after pioglitazone 23285.194936
GSM201840Muscle PCOS after pioglitazone 252102.73441
GSM201841Muscle PCOS after pioglitazone 272125.14852
GSM201842Muscle PCOS after pioglitazone 32127.70955
GSM201843Muscle PCOS after pioglitazone 42104.15142
GSM201844Muscle PCOS after pioglitazone 82138.54952